PZVSX
Price
$15.52
Change
-$0.26 (-1.65%)
Updated
Dec 17 closing price
VSIAX
Price
$88.58
Change
-$1.09 (-1.22%)
Updated
Dec 17 closing price
Ad is loading...

PZVSX vs VSIAX

Header iconPZVSX vs VSIAX Comparison
Open Charts PZVSX vs VSIAXBanner chart's image
Pzena Small Cap Value Investor
Price$15.52
Change-$0.26 (-1.65%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$88.58
Change-$1.09 (-1.22%)
VolumeN/A
CapitalizationN/A
PZVSX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PZVSX vs. VSIAX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PZVSX is a StrongSell and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. PZVSX (64.4M). VSIAX pays higher dividends than PZVSX: VSIAX (2.01) vs PZVSX (0.12). PZVSX was incepted earlier than VSIAX: PZVSX (9 years) vs VSIAX (13 years). PZVSX is a more actively managed with annual turnover of: 28.00 vs. VSIAX (16.00). VSIAX has a lower initial minimum investment than PZVSX: VSIAX (3000) vs PZVSX (5000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. PZVSX (8.14). VSIAX return over 5 years is better than : 52.83 vs. PZVSX (33.98).
PZVSXVSIAXPZVSX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence9 years13 years-
Gain YTD6.08315.03140%
Front LoadN/AN/A-
Min. Initial Investment50003000167%
Min. Initial Investment IRAN/AN/A-
Net Assets64.4M63B0%
Annual Yield % from dividends0.122.016%
Returns for 1 year8.1416.2350%
Returns for 3 years12.6220.6761%
Returns for 5 years33.9852.8364%
Returns for 10 yearsN/A105.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics